RDIF, Panacea Biotec partner to produce Sputnik V in India First batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Centre for quality control. Full-scale production of the vaccine is due to start soon BusinessToday.In | May 24, 2021 | Updated 16:22 IST Sputnik V vaccine got the emergency use authorisation in the country on April 12 Russia's sovereign wealth fund RDIF (Russian Direct Investment Fund) and homegrown pharma company Panacea Biotec have partnered to launch the Russian Sputnik V vaccine in India. The RDIF has already tied up with Dr Reddy's to produce the vaccine in India. Both have agreed to produce 100 million doses per year of Sputnik V.